These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 2743373
1. Efficacy of mexiletine in ventricular arrhythmias among patients in Taiwan: assessment by 24-hour Holter electrocardiography. Hwang YS, Wang JL. Clin Ther; 1989; 11(3):392-7. PubMed ID: 2743373 [Abstract] [Full Text] [Related]
2. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias]. Purcaro A, Massacci C, Curzi G, Pigini G, Costantini C, Bilancini A, Blandini A. G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727 [Abstract] [Full Text] [Related]
3. [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine]. Zehender M, Geibel A, Hust M, Hohnloser S, Meinertz T, Just H. Z Kardiol; 1987 Aug; 76(8):501-6. PubMed ID: 2445118 [Abstract] [Full Text] [Related]
4. Efficacy of mexiletine in chronic ventricular arrhythmias: a multicentre double-blind medium-term trial. Poggesi L, Scarti L, Ieri A, Lanzetta T, Grazzini M, Del Bene P, Masini G, Del Citerna F, Carnovali M, Masotti G. Int J Clin Pharmacol Res; 1989 Aug; 9(4):269-75. PubMed ID: 2476406 [Abstract] [Full Text] [Related]
5. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)]. Bellocci F, Ansalone G, Scabbia E, Santarelli P, Lucente M, Affinito V, Loperfido F, Zecchi P. G Ital Cardiol; 1981 Aug; 11(4):488-97. PubMed ID: 6169580 [Abstract] [Full Text] [Related]
6. [Propafenone and flecainide in the therapy of ventricular arrhythmias]. Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL. Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814 [Abstract] [Full Text] [Related]
7. [Treatment of ventricular arrhythmia with mexiletine (Mexitil), monitored by Holter ambulatory electrocardiography]. Garimoldi M, Pirastu A, Barbanotti G, Sghirinzetti M, Catalano M, Castelfranco M. Minerva Cardioangiol; 1988 Apr; 36(4):159-65. PubMed ID: 3173699 [No Abstract] [Full Text] [Related]
8. Mexiletine: long-term efficacy and hemodynamic actions in patients with ventricular arrhythmia. Sami M, Lisbona R. Can J Cardiol; 1985 Apr; 1(4):251-8. PubMed ID: 2413974 [Abstract] [Full Text] [Related]
9. Mexiletine in ventricular arrhythmias--an assessment by 24 hours holter monitoring. Gambhir DS, Khalilullah M, Bahl VK. Indian Heart J; 1984 Apr; 36(3):142-6. PubMed ID: 6490043 [No Abstract] [Full Text] [Related]
10. [Mexiletine in patients with progressive infarction and reduced ventricular function: anti-arrhythmic efficacy and hemodynamic effects]. Zacà F, Ghinelli M, Bombardini T, De Collibus C, Zaccaria O, Steffanon L, Azzolini U, Valentini P, Puddu P. G Ital Cardiol; 1990 Jun; 20(6):569-75. PubMed ID: 2227228 [Abstract] [Full Text] [Related]
11. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes. Capucci A, Di Pasquale G, Boriani G, Carini G, Balducelli M, Frabetti L, Carozzi A, Finzi A, Pinelli G, Magnani B. Int J Clin Pharmacol Res; 1991 Jun; 11(1):23-33. PubMed ID: 1714885 [Abstract] [Full Text] [Related]
12. [Ventricular arrhythmias and left ventricular function in coronary artery disease. A study by M-mode echocardiography and 24-hour Holter-monitoring (author's transl)]. Koenig W, Schinz A, Bungeroth KA, Halhuber MJ, Hofmann H, Kollmann G. Z Kardiol; 1981 Mar; 70(3):158-62. PubMed ID: 7234046 [Abstract] [Full Text] [Related]
14. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias. Meinertz T, Kasper W, Stengel E, Waldecker B, Löllgen H, Jähnchen E, Bechtold H, Just J. Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160 [Abstract] [Full Text] [Related]
15. Mexiletine for the treatment of ventricular arrhythmias associated with chronic obstructive pulmonary disease. Fracalossi C, Ziacchi V, Farisè F, Rossi A, Marino A, Lomanto B, Moretti L. G Ital Cardiol; 1989 Jan; 19(1):46-52. PubMed ID: 2744314 [Abstract] [Full Text] [Related]
16. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial. Trimarco B, Volpe M, Ricciardelli B, Sacca' L, De Luca N, Rengo F, Condorelli M. Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721 [Abstract] [Full Text] [Related]
17. Pharmacokinetics and the antiarrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias. Ohashi K, Ebihara A, Hashimoto T, Hosoda S, Kondo K, Oka T. Arzneimittelforschung; 1984 Dec; 34(4):503-7. PubMed ID: 6540110 [Abstract] [Full Text] [Related]
18. [Treatment of arrhythmias with high risk of sudden death in chronic Chagas' cardiopathy with oral mexiletine. Evaluation with 24-hour ambulatory electrocardiographic monitoring (Holter)]. Sgammini HO, Evequoz MC, Chuit R, Atti R, Santamarina NO, Kuschnir E. Arq Bras Cardiol; 1983 Feb; 40(2):103-9. PubMed ID: 6354146 [No Abstract] [Full Text] [Related]
19. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias. Van Durme JP. Acta Cardiol Suppl; 1980 Feb; (25):121-5. PubMed ID: 6990664 [Abstract] [Full Text] [Related]
20. International Mexiletine and Placebo Antiarrhythmic Coronary Trial (IMPACT): II. Results from 24-hour electrocardiograms. IMPACT Research Group. Eur Heart J; 1986 Sep; 7(9):749-59. PubMed ID: 3533546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]